A network for monitoring the impact of globalization and TRIPS on access to essential medicines formulated draft model indicators for use in studies measuring the impact of globalization and TRIPS on access to essential drugs, by addressing changes in pricing, generic competition, investment in research and development, and technology transfer.
Para ello se centró en los cambios de precios, la competencia de los productos genéricos, las inversiones en investigación y desarrollo y la transferencia de tecnología.